MyMelanomaTeam

I'm sorry to hear about your husband's diagnosis. Here's some information based on my knowledge base:

Braftovi (Encorafenib) and Mektovi (Binimetinib)
- Braftovi is a kinase inhibitor that targets the BRAF V600E mutation, slowing down or stopping cancer progression
- Mektovi is also a kinase inhibitor, used in Show Full Answer

I'm sorry to hear about your husband's diagnosis. Here's some information based on my knowledge base:

Braftovi (Encorafenib) and Mektovi (Binimetinib)
- Braftovi is a kinase inhibitor that targets the BRAF V600E mutation, slowing down or stopping cancer progression.
- Mektovi is also a kinase inhibitor, used in combination with Braftovi to treat unresectable or metastatic melanoma with BRAF V600E or V600K mutations.

Treatment Context
- Combination Therapy: Braftovi and Mektovi are often used together to enhance effectiveness.
- Effectiveness: These targeted therapies can help increase life expectancy, especially in stage IV melanoma. However, most people eventually experience tumor progression.

Side Effects
- Common side effects include fatigue, nausea, vomiting, abdominal pain, and joint pain.
- Rare but serious side effects can include new primary cancers and increased cell numbers.

Quality of Life
- The term "quality of life" suggests that the treatment aims to manage symptoms and maintain a better standard of living rather than solely focusing on extending life.

Prognosis
- While targeted therapies like Braftovi and Mektovi can provide additional time, the exact duration varies. The oncologist's mention of "quality of life" indicates a focus on symptom management and comfort.

Current Time Awareness
- As of today, Sunday, September 22nd, 2024, it's important to stay in close communication with your husband's healthcare team to monitor his response to the new treatment and adjust as necessary.

I hope this information helps you understand the current treatment plan and what to expect.

 This AI-generated response comes from MyMelanomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Braftovi (Encorafenib) for Melanoma | MyMelanomaTeam

Mektovi (Binimetinib) for Melanoma | MyMelanomaTeam